UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported)

September 12, 2014

 


 

VIVUS, INC.

(Exact name of registrant as specified in its charter)

 

Delaware

 

001-33389

 

94-3136179

(State or other jurisdiction of
incorporation)

 

(Commission File Number)

 

(IRS Employer
Identification No.)

 

351 EAST EVELYN AVENUE

MOUNTAIN VIEW, CA 94041

(Address of principal executive offices, including zip code)

 

(650) 934-5200

(Registrant’s telephone number, including area code)

 

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

o            Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o            Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o            Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 



 

Item 5.07.  Submission of Matters to a Vote of Security Holders

 

On September 12, 2014, VIVUS, Inc., or the Company, held its 2014 Annual Meeting of Stockholders, or the Annual Meeting.  At the Annual Meeting, the Company’s stockholders elected seven directors to serve until the next Annual Meeting of Stockholders or until their successors are duly elected and qualified; approved, on an advisory basis, the Company’s executive compensation; ratified the Company’s appointment of OUM & Co. LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2014; and approved an amendment to the Company’s 2010 Equity Incentive Plan to increase the number of authorized shares reserved for issuance thereunder by 5,950,000 shares.  As previously disclosed, the Company intends to continue to solicit stockholder approval, on an advisory basis, of the Company’s executive compensation on an annual basis at least until the next advisory vote on the frequency of stockholder advisory votes occurs.  The next advisory vote regarding the frequency of stockholder advisory votes on executive compensation is required to occur no later than the Company’s 2017 Annual Meeting of Stockholders.

 

The Company’s independent inspector of election reported the voting results as follows:

 

(i)  Election of seven directors to serve until the next Annual Meeting of Stockholders or until their successors are duly elected and qualified:

 

Name

 

For

 

Withheld

 

Broker Non-Votes

 

Samuel F. Colin, M.D.

 

33,240,903

 

4,906,010

 

45,818,506

 

Alexander J. Denner, Ph.D.

 

27,059,579

 

11,087,334

 

45,818,506

 

Seth H. Z. Fischer

 

34,510,972

 

3,635,941

 

45,818,506

 

Johannes J.P. Kastelein, M.D., Ph.D.

 

24,542,112

 

13,604,801

 

45,818,506

 

David Y. Norton

 

34,339,985

 

3,806,928

 

45,818,506

 

Jorge Plutzky, M.D.

 

34,358,144

 

3,788,769

 

45,818,506

 

Herman Rosenman

 

34,261,827

 

3,885,086

 

45,818,506

 

 

(ii)  Approval of, on an advisory basis, the Company’s executive compensation:

 

For

 

Against

 

Abstain

 

Broker Non-Votes

 

31,178,589

 

4,087,044

 

2,881,280

 

45,818,506

 

 

(iii)  Ratification of the appointment of OUM & Co. LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2014:

 

For

 

Against

 

Abstain

 

Broker Non-Votes

 

79,597,148

 

3,411,201

 

957,070

 

0

 

 

(iv)  Approval of an amendment to the Company’s 2010 Equity Incentive Plan to increase the number of authorized shares reserved for issuance thereunder by 5,950,000 shares:

 

For

 

Against

 

Abstain

 

Broker Non-Votes

 

34,550,167

 

3,412,141

 

184,605

 

45,818,506

 

 

2



 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

VIVUS, INC.

 

 

 

 

By:

/s/ John L. Slebir

 

 

John L. Slebir

 

 

Senior Vice President, Business Development and General Counsel

 

 

 

Date: September 16, 2014

 

 

 

3